Search for: "Roche v. Roche" Results 421 - 440 of 925
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Aug 2023, 12:57 pm by Rebecca Tushnet
Individual interest v. public interest opposed in those cases and in Kirtsaeng. [read post]
7 Sep 2010, 6:10 pm by Kelly
Patent and Trademark Office et. al, (Prior Art) US: District Court New Jersey: Drug label may provide evidence of intent to induce infringement even though required by the FDA: Hoffmann-La Roche Inc. v. [read post]
25 Aug 2010, 12:37 am by Kelly
(Patent Docs) Ablify (Aripiprazole) – Australia: Allowability of amendments under section 102 of the Patents Act (IP Whiteboard) Boniva (Ibandronate) – US: Patent infringement complaint filed following a Paragraph IV certification:  Hoffman-La Roche Inc. v. [read post]
5 May 2010, 4:46 am
(Patent Docs) (GenericsWeb) Valcyte (Valgancyclovir) – India: Roche loses Valcyte case (Spicy IP) (Generic Pharmaceuticals and IP) Vanos (Fluocinonide) – US: Patent infringement complaint in response to Para IV certification: Medicis Pharmaceutical Corp. v. [read post]
10 Nov 2010, 1:11 am by Kelly
Becton-Dickinson (Patent Docs) US government intervenes in patentability of genes – AMP v USPTO (Patent Baristas) (Holman’s Biotech IP Blog) (Intellectual Property Law Blog) (Inovia) (BlawgIT) (IP Osgoode) US: BIO and AUTM fire back at gene patent foes – AMP v USPTO (Patent Baristas) (Patent Docs) US: IPO files amicus brief in AMP v USPTO (Patent Docs) (Patent Baristas) US: AIPLA submits amicus brief in AMP v USPTO (Patent Docs) US: Summary of… [read post]
13 Feb 2013, 4:08 pm by INFORRM
Kirby v Daily Telegraph, 13 August 1998, Roch, Ward and Potter LJJ, held that a previous judgment in a libel case was final and could not be reopened. [read post]
21 Oct 2011, 12:29 pm by Aaron Barkoff
Patent System: The Impact of Reform on Biotech Patent Strategies Examining 35 U.S.C. 101 Subject Matter Patentability in the Wake of Myriad and Prometheus Microsoft v. i4i and Stanford v. [read post]
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
22 Mar 2011, 4:21 pm by Marie Louise
Brownback’s 2010 version (FDA Law Blog) US: Effective March 28, 2011 – New safety reporting requirements for certain drug and biological products (FDA Law Blog) US: FDA issues new guidance on PDUFA user fee waivers, reductions, and refunds; guidance represents the culmination of 18 years of FDA experience (FDA Law Blog) US: Affymetrix files for correction of inventorship: Affymetrix v Illumina (Patent Docs) US: Hoffman-La Roche files for review and correction of patent… [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog)   Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on… [read post]
3 Dec 2016, 10:02 am
No problem, here is the 124th edition of Never Too Early For Christmas References Never Too Late.Festive Feline Level 100Rocket in the Patents Court: Napp Pharmaceutical v Dr Reddy's and SandozThe case of Napp Pharmaceutical Holdings Limited v (1) Dr Reddy's Laboratories (UK) Limited (2) Sandoz Limited [2016] EWCA Civ 1053 was previously reported on the IPKat here (first instance) and here (interim application). [read post]
8 Oct 2009, 6:05 am
Hoffmann-La Roche (Patent Docs) Razadyne (Galanthamine) - US: CAFC: You can’t rely on test results that weren’t available when your patent application was filed: Janssen Pharma and Synaptech v. [read post]
15 Sep 2010, 2:40 am by Kelly
(Afro-IP) Africa: Giving consumers power in the battle against counterfeits (Afro-IP) Australia: Review Four Corners’ ‘Body Corporate’ program on gene patenting (Patentology) India: Roche and Novartis, finally, manage to defend their patents in oppositions filed by Cipla (Spicy IP) South Africa: San people push for new legislation – demand protection for indigenous knowledge and IP including medicinal remedies derived from plants including Hoodia (Afro-IP) US:… [read post]